The latest news from academia, regulators
research labs and other things of interest
Posted: Jan 23, 2013
Nanotechnology in Australia - companies, research, and degree programs
(Nanowerk News) Until December 2012, Australia had no formal national nanotechnology initiative, though a series of national networks and programs have been established to bring together relevant research. On December 7, 2012, the National Nanotechnology Research Strategy (pdf) was launched. Outlining a bold vision for a nanotechnology enabled Australian Economy; the research strategy highlights a range of existing and emerging nanotechnology applications. The strategy includes eight key recommendations for strategic investment and coordination considered essential for supporting Australian nanotechnology research and effective translation of that research into benefits for the community. This research strategy goes on to highlight Australia’s current research strengths across a broad range of nanotechnology disciplines and subsequently identify opportunities for these strengths to be leveraged over the coming decade.
There is significant government investment in Australian nanotechnology research from the Australian Research Council and the Commonwealth Scientific and Industrial Research Organization as well as funding from state governments. There are two industry-wide bodies:
The Australian Nanotechnology Network (ANN)(formerly ARCNN) is dedicated to substantially enhancing Australia’s research outcomes in this important field by promoting effective collaborations, exposing researchers to alternative and complementary approaches from other fields, encouraging forums for postgraduate students and early career researchers, increasing nanotechnology infrastructure, enhancing awareness of existing infrastructure, and promoting international links.
The Australian Nanotechnology Alliance is an industry-led, research supported membership-based alliance comprising organisations that underpin Australia's current and future economic growth in diverse industry sectors including mining, manufacturing agriculture, construction, biotechnology, marine, aviation and microelectronics.
Currently, there are 40 companies in Australia involved in nanotechnology-related business activities.
In addition, there are 76 nanotechnology and nanoscience-related research and community organizations in Australia.
Anteo Diagnostics specialises in the development and commercialisation of proprietary surface coatings for applications in the diagnostics and biotech industries. With Mix&Go we have developed ?molecular glues? which are used by our partners and customers to immobilize delicate biological molecules such as antibodies to synthetic surfaces.
Commercializes a nano and micron sized ceramic spheres technology that provides encapsulation and controlled release of active molecules for a variety of applications including drug delivery, cosmeceuticals and speciality chemicals.
Living Cell is developing cell-based products to treat life threatening human diseases. The company has developed proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell, to be implanted without the use of toxic immune suppressive drugs.
Following several years research into the new and exciting advancement in the emerging nanotechnology industry, Healthy Channels Pty Ltd was established to bring some of this technology to the general public. One specific technology, known as Silversure, utilises the latest advances in Silver Nanotechnology Antimicrobial Protection.
ATA Scientific specialises in marketing and servicing analytical and scientific instruments with a products focus on the Particle Sciences, Biotechnology and Spectroscopy. They include instruments applicable to nano particle, micro emulsion and bio-surface research.
Biomimetics Pty Ltd has developed an innovative enabling technology to coat bone-like nanohydroxyapatite for the production of an unique synthetic bone graft material that has increased superiority in bioactivity, strength controlled solubility and drug delivery over similiar products already in the market. It is a platform technology with a wide range of applications.
Evolved from more than 15 years research at Sydney's Macquarie University, BluGlass has invented a novel process using Remote Plasma Chemical Vapour Deposition (RPCVD) to grow semiconductor materials such as gallium nitride (GaN), crucial to the production of high efficiency devices including next generation lighting technology Light Emitting Diodes (LEDs) at a fraction of the current cost.
Designs, manufactures and markets a range of scientific instruments comprising Atomic Absorption spectrometers (AAS), UV-Visible spectrometers (UV-Vis), Inductively Coupled Plasma Optical Emission spectrometers (ICP-OES), Inductively Coupled Plasma Time of Flight Mass spectrometers (ICP-TOFMS), High Performance Liquid Chromatographs (HPLC) and Rheological Analysis Equipment.
The Micro-Bio-Nano Company. MiniFAB offers customized manufacturing and advanced product development, exploiting leading edge polymer microfabrication. The company's business is the design, fabrication and integration of polymer microengineered systems.
Nanocoatings Pty Ltd has developed an innovative enabling technology to coat hydroxyapatite for the production of an unique synthetic bone graft material. More bioactive and with greatly increased durability and strength over other synthetic bone graft substitutes.
Quickstep, or more specifically, the Quickstep Process, is a range of unique and patented technologies that can be used in the out-of-autoclave manufacture of advanced composite materials, including nanocomposite production.
TenasiTech is commercializing Adaptive Polyol - a new way of incorporating patented, high functioning nanoscale additives in polymer precursors for maximum flexibility, consistency and performance. In addition we are supplying the additives themselves for incorporation in finished polymers.
Bridge8 advises small and medium size organisations where creating vision and making connections between organisations and their communities is vital to success. Bridge8 brings specific capabilities in foresight and strategy facilitation and development, and marketing and communications for science and technology.
A university technology transfer group in Australia. A subsidiary company of The University of Queensland, UniQuest identifies, packages and commercializes the university technologies and expertise, including nanotechnology.